“The next level biotechnology offers the opportunity to build our bio-renewable future.”
Dutch innovation campus Biotech Campus Delft, owned by multinational Royal DSM, and tech incubator YES!Delft have teamed up to support biotechnology start-ups through a special ‘Biotech Validation Lab’. Under the initiative, biotech start-ups can apply to join the programme to validate their business plan and to define a clear strategy to success.
Both organisations support promising biotech start-ups to accelerate innovations and boost the transition towards a bio-based economy.
The validation programme is open to European start-ups with innovative technologies and disruptive solutions in industrial biotechnology.
Technology fields in the scope of the programme are genetic and metabolic engineering, fermentation and downstream processing. The scope of application includes food, fuel, bio-based molecules, and bio-materials. In a statement, Biotech Campus Delft said the "ten best teams will be selected and invited to join the Validation Lab".
Each team will be matched with relevant mentor(s) from biotech-related business and/or technical experts, all leading professionals in their field. During 12 sessions the start-ups will be trained on opportunity framing, customer validation, team building, pitching and value proposition design.
Biotech Campus Delft (@BiotechDelft) offers this program free of charge to the selected start-ups. On the final day of the Validation Lab, the teams pitch their business plan for a jury. There will be an additional prize for the best startup: a voucher providing office space and a lab at Biotech Campus Delft.
Calls for entry are open now and the deadline for completed entries is 5 April,2019. The Biotech Validation Lab takes place from May until July in Delft, the Netherlands. The start-ups will present their pitches after the 10-week learning journey in the Validation Lab on the final day on July 31st, 2019.
Cindy Gerhardt, Business Director Biotech Campus Delft, said: “We are very excited about this partnership with YES!Delft. The next level biotechnology offers the opportunity to build our bio-renewable future. However, operating a startup in this field can represent a challenge due to the capital investments, scale up hurdles and long development times related to it.
“The Biotech Campus Delft, its main stakeholder Royal DSM and YES!Delft understand these challenges and are determined to support the start-ups in this field to define a clear strategy to success.”
“YES!Delft is very pleased to partner with Biotech Campus Delft,” added Evert Jaap (EJ) Lugt, managing director of YES!Delft.
“Bundling our strengths, their industrial expertise with our unique incubator ecosystem, we can make a real impact in biotech innovation. The Biotech Validation Lab will be an amazing opportunity for start-ups with top-notch ideas to accelerate and be part of the transition to a sustainable bio-based future.”